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Description of the Clinical Problem 
According to the National Cancer Institute approximately 1,735,350 Americans 
will be diagnosed with cancer in 2018 (American Cancer Society, 2018) .  It is estimated 
that 30%-50% of those patients receiving treatment will experience pain caused by 
malignancy or the cancer therapy itself.  Regrettably, 70-90% of those with metastatic 
disease will encounter severe discomfort, due most often to tumor burden at secondary 
sites (Platt, 2010).   
Uncontrolled pain is distressing and leads to poor functionality, decreased 
emotional well-being, unplanned Emergency Department (ED) visits, and unanticipated 
hospital admissions (UHA) (Numico et al., 2015; Rocque et al., 2013).  For example, 
from 2006-2012, 29.5 million (4.2%) adult Emergency Department (ED) visits were 
attributed to uncontrolled oncologic symptoms (Rivera et al., 2017). The inability to 
complete daily tasks including ambulation, dressing, feeding, and toileting of oneself 
instigates fear and lack of self-control, resulting in depression and anxiety in one-quarter 
of the population (Jacobsen & Jim, 2008).  Further studies found those harboring 
depressive symptoms in the setting of advanced cancer had a 25% increased risk of 
mortality and were 4 times more likely to hasten death (Jacobsen & Jim, 2008).  
A 2012-2016 study aimed at decreasing ED and hospital admissions found that 
patients given an earlier palliative care referral (PCR) had 18.1% less ED visits and 
12.5% less acute hospital admissions versus late PCRs (Michael et al., 2019). In response 
to the evidence, the American Society of Clinical Oncology (ASCO) updated its 
guidelines in 2016, recommending the integration of PC into standard oncology care: 
“Patients with advanced cancer should be referred to interdisciplinary PC teams that 
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provide inpatient and outpatient care early in the course of disease, alongside active 
treatment of cancer” (Ferrell et al., 2017).   
Assessing pain alone does not acknowledge the interconnectedness of 
psychosocial, spiritual, and physical duress.  To discount these relationships contributes 
to insufficient treatment leading to unnecessary suffering, poor quality of life, and 
inferior health outcomes.   
A survey conducted amongst all physicians with patient care responsibilities, 
belonging to the Easter Cooperative Oncology Group (ECOG), found 76% of oncologists 
specified poor pain assessment as the most significant impediment to appropriate pain 
management (Von Roenn, Cleeland, Gonin, Hatfield, & Pandya, 1993).  Therefore, a 
proper pain evaluation must be an essential component of the oncologic treatment plan. 
This evaluation assists in determining pain severity as well as the extent of its physical 
and emotional impact. With this tool, a clinician is more able to manage oncologic 
symptoms in high-risk patients frequently utilizing the ED or are admitted to the hospital.  
Description of Project, Eligibility Criteria, and Primary Aims 
This project implemented an algorithmic approach to assess pain, functionality, 
and psychosocial states in newly diagnosed cancer patients, utilizing a validated pain 
tool, within a second-year-fellow Hematology/Oncology clinic, with intent to identify 
patients at high-risk for ED admission or UHA.    
The second-year-fellow Hematology/Oncology clinic site services approximately 
450 patients per year. Clinic hours occurred on Thursday afternoons (1200-1600) during 
a 3-month data collection period.  Prior to this project, this site had not utilized a formal 
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comprehensive pain assessment tool. Hence, baseline data on prior institutional 
performance was not available. 
To be eligible to participate within this study, patients needed have a new cancer 
diagnosis or subsequent recurrence and were presenting for consultation prior to starting 
treatment.  Additionally, the patient had to have decision-making capacity as well as the 
ability to independently communicate and read English at a fifth-grade level.  
Primary aims for this project included: (a) aggregating demographic data to 
determine the profile of a high-risk patient seen within this clinic, (b) determining those 
referred to and who followed up with symptom specialists or the ED, and (c) identifying 
barriers for next iteration of the project.   
Secondary goals included: (a) assessing the effectiveness of a Comprehensive 
Pain Assessment tool in helping to identify pain, psychosocial, functional, spiritual 
distress, and substance abuse potential in patients newly diagnosed with cancer, (b) 
providing thorough education on pharmacological and nonpharmacological modalities to 
reduce pain, (c) explaining the purpose and misconceptions of PC, and (d) managing 
symptoms and/or providing referrals for appropriate interventions in a timely manner to 
improve patient satisfaction and health outcomes. 
Project Plan Process 
Following stakeholder and IRB approval, a provider documentation template in 
the electronic medical record (EMR) was created.  Information within the note was based 
on a validated Adult Oncology Outpatient Comprehensive Pain Assessment Tool. 
During data collection, a weekly chart review was completed by the investigator 
to identify patients for consultation and confirmed with the consulting oncologist.  Prior 
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to assessment, patients were given an Information Letter for Research explaining the 
intentions of the project and that involvement was voluntary (Appendix A). 
The pain assessment was administered by the investigator during the patient 
encounter.  If a need for pain or symptom management, mental health services, social 
work, or nurse navigation was identified, referrals were provided during that visit.  
At the conclusion of the data collection period, the investigator performed a chart 
review of all eligible patients, aggregating and analyzing data.  Additionally, a post-
implementation survey was conducted amongst the second-year fellows. Upon the 
completion of both patient and physician data analysis, potential improvements to the 
process were determined and presented to stakeholders. 
Project Site 
The site in which this project was conducted had recently merged with a world-
renowned cancer center.  To comply with the cancer center’s standards, specific 
oncologic algorithms and protocols are to be adopted into practice over an unspecified 
time.  For this reason, the Adult Oncologic Comprehensive Pain Assessment was 
accepted as a validated tool by the facilitators without difficulty. 
Framework 
The Plan Do Check Act (PDCA) model, also known as the Shewart or Deming 
cycle, is a highly-utilized tool in continuous process improvement (CPI).  The 
investigator must plan an intervention to a problem using evidenced-based practice, do 
the necessary steps to achieve the potential solution, check the outcome(s) of the 
implemented intervention, making necessary revisions, and then act on the revisions by 
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implementing the best solutions. Ideally, this sequence should persist until the desired 
outcome has been achieved (Johnson, 2002).   
The Planning phase consisted of the project proposal to stakeholders, 
development of project materials, and IRB application with approval. In the Do phase, 
the eligible patients were identified, the Comprehensive Pain Assessment was 
administered, and data were collected over 3 months. Data analysis and manuscript 
development by the investigator occurred during the Check phase.  Final data were 
presented to stakeholders at the conclusion of the project to collect feedback on 
identifiable barriers and potential iterations for next the attempt.  Finally, the Act phase 
required the agreed-upon revisions to be completed on the next PDCA cycle. This PDCA 
framework was chosen to assist in the execution of the project due to its ease of 
application, pertinence in the clinical environment, and familiarity within the institution 
where the intervention was implemented.   
Project Approval and Timeline 
Initial project approval was obtained by presenting an implementation outline, 
and evidence supporting the importance of comprehensive pain assessment in newly 
diagnosed oncology patients to the providers on August 6, 2018 (Appendix B). An IRB 
application was submitted to the health care organization on September 28, 2018. 
Approval was obtained on November 15, 2018.  An application for IRB approval from 
the University of San Diego was subsequently submitted and approved by December 4, 
2018 (Appendix C-D).    
The 3-month data collection period commenced on December 6, 2018. Patients 
were seen by the investigator in clinic every Thursday afternoon until February 28, 2019.   
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At the conclusion of this period, chart reviews were performed on eligible patients 
and data were analyzed for the next 21 days.  A post-implementation survey was given to 
all second-year fellows for feedback. 
Stakeholders 
The project data, evaluation, and communication plan were discussed at length 
and unanimously agreed upon in an initial meeting with all stakeholders.  A projected 
timeline of 4 months from the creation of a standardized EMR-provider note to 
completion of data collection was established.  Regular meetings with the stakeholders 
were scheduled to discuss progress, obstacles, and potential solutions. Outcomes were 
also shared with five patients who were screened over the 3-month period.  
Databases and Search Terms 
PubMed, UpToDate, and Google Scholar were databases searched to identify 
high-risk patient literature utilizing standardized comprehensive pain assessment to 
reduce ED visits and hospital admissions. Further, these publications were evaluated for 
the improvement of quality of care, patient satisfaction, and health outcomes.  Common 
search terms included oncology, pain, oncologic pain, assessment, palliative care, and 
symptom management.  At the conclusion of the literary search, 118 articles were 
critically reviewed.  Twelve of those articles were used for supporting evidence for this 
project. 
Evidenced-Based Solutions 
Standardized Electronic Medical Record (EMR) Provider Documentation 
 In the United States, it is commonplace for large-scale, academic medical 
practices to utilize an EMR system. In addition to improved documentation, it is also a 
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helpful tool to assist in the identification of desired patient populations. Further, the EMR 
can alert the clinician to screen specific high-risk populations and place appropriate, 
timely orders.   
The clinic utilized the EPIC EMR system in which this intervention was 
employed.  A provider documentation note template was created and replicated the 
information required on the Comprehensive Pain Assessment Tool.  The note could be 
utilized by all EPIC users by typing the shortcut “COMPPAIN.”  The template was 
designed to self-populate patient information including name, date of birth, age, medical 
record number, sex, diagnosis, medications, and allergies.  Additionally, all assessment 
questions related to pain, functionality, and psychosocial issues were listed as they 
appeared on the original tool.  Free text could be entered into the plan and assessment 
portion of the record.  A disclaimer explaining that the patient had been given literature 
prior to the assessment and verbally consented to the study concluded the documentation.  
Comprehensive Pain Assessment for High-Risk Patients 
The Adult Oncology Outpatient Comprehensive Pain Assessment was developed 
from evidenced-based literature and was designed specifically for the adult outpatient 
oncology population, not including pregnant women.  This tool not only assessed the 
patient’s current level of pain, but also past and present psychosocial states, perceived 
functionality in completing activities of daily living, expectations of pain control, and 
potential problems with addiction (Appendix E). 
Clinician Education  
A 10-minute meeting with the second-year fellows was held prior to project 
implementation explaining the importance of a comprehensive pain assessment in the 
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outpatient adult oncology population as early in the diagnosis as possible.  An electronic 
notice summarizing the project, patient eligibility criteria, process of identifying eligible 
patients, and project timeline was sent to all stakeholders prior to data collection.  
Process and Outcome Indicator Data Monitoring 
Chart Review 
 During the data collection period, the patient panel was reviewed every Thursday 
morning to identify eligible patients from the new consultations.  Findings were then 
discussed and agreed upon with the oncologist treating the patient.  Additionally, all 
eligible patients’ charts were reviewed both during and at the conclusion of data 
collection to determine if and when they followed up, presented to the ED, or were 
unexpectedly hospitalized.   
Post-Implementation Clinician Survey 
The second outcome indicator for data monitoring included a 5-question survey 
sent to the three fellows 1-week post data collection. The survey was relayed and 
returned through a confidential email system (Table 1). 
Table 1 
Post-Implementation Clinician Survey Results 
Do you feel the Comprehensive Pain Assessment: Yes No Cannot 
Determine 
Benefited your newly diagnosed patients? 3 0 0 
Was an efficient and effective use of time? 3 0 0 
Improved your patients’ outcome? 2 0 1 




Aim 1: Demographic Information 
During the 3-month data collection period, 121 patients were seen.  Of those 
patients, 56 were new consultations and 14 fit eligibility criteria.  The Comprehensive 
Pain Assessment Tool was administered to 5 of those patients (Figure 1). 
 
Figure 1. Number of patients and consultations. 
Of the 14 eligible patients 4 were male and 10 were female.  Median age was 70 
years old with an age range of 56-90 years old.  The most prominently diagnosed cancers 
were Stage IV breast and gynecological malignancies.  Four patients were not 
pathologically diagnosed or staged at the time of the first consultation.  Of the five 
patients administered the pain assessment, 100% of them were female with Stage IV solid 




















Demographic Information Data Analysis 
 Not Seen (%) 
(n = 9) 
Consulted (%) 











≤ 70 years 


















Skin (BCC of chest) 
Nerve Sheath Tumor 
Unknown 






































Aim 2: Baseline Data 
Eighty-six percent of patients were correctly identified as being high-risk.  Three 
of the five patients administered the pain assessment were given PC referrals and 
subsequently followed up.  One patient was referred to a nurse navigator and had been 
contacted by the service. One of the patients referred to PC was appropriately placed on 
hospice and expired according to her wishes within 48 hours of completing Advanced 
Directive and Physician Order for Life Sustaining treatment forms.  One of the 5 patients 
not referred was admitted to the ED and hospitalized (Table 3) 
Table 3 
Hospitalizations and Emergency Department (ED) Visits 
 Not Seen (%) 
(n = 9) 
Consulted (%) 
(n = 5) 
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 Three of the five patients administered the comprehensive pain assessment tool 
presented to the ED and were hospitalized. Two of the nine patients not seen were 
admitted to the ED and hospitalized.  The most prominent causes for ED admission were 
shortness of breath and pain. One patient who was identified as an eligible, high-risk 
patient was not referred by the oncologist because they believed the patient appeared to 
be “too overwhelmed.”  Unfortunately, this patient had four ED admissions and one 
hospitalization related to shortness of breath.   
Aim 3: Barriers and Potential Solutions 
 After completion of the data collection period and subsequent analysis, several 
barriers were recognized. The first obstacle to this study was a small sample size.  As the 
data suggested, solid tumor as well as breast and gynecological cancers were the most 
prevalent. A potential solution may be to implement this intervention in a solid tumor 
clinic such as breast, gynecology oncology, gastrointestinal, prostate, or lung.  
The second barrier was under-consultation of eligible patients.  Possible reasons 
for this may have been a lack of clarity on patient eligibility criteria, miscommunication 
on the purpose of assessing not only pain but psychosocial and functional states, the 
physician’s belief that the patient did not require the intervention, or the patient refused 
the intervention.  On the next iteration of this project, a more in-depth presentation and 
education on patient eligibility criteria, how to better identify high-risk patients, and the 
components of the pain assessment tool should be provided to both providers and medical 
assistants responsible for rooming the patients.  Additionally, to avoid patients’ refusal 
due to feeling overwhelmed on their first visit, assessing the patient within the first three 
visits should be considered.  
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The third hinderance was the lack of a dedicated space for consultation. The 
Hematology Oncology clinic in which this project was implemented had limited patient 
rooms and private space.  A quiet, comfortable area with ample seating, space for 
literature, and a computer would be an ideal location to conduct such a visit.  An exam 
room would be helpful should a more in-depth physical evaluation to assess pain and/or 
functionality be required; however, it is not necessary as these patients had just been 
examined by the oncologist. Additionally, it would be helpful for the investigator to be in 
or around the oncologists during clinic hours.  This would allow for discussion of patient 
needs and unanticipated issues. 
The fourth short-coming was the inability to assess patient satisfaction and health 
outcomes. Due to the limited 3-month data collection period, it was difficult to determine 
long-term health outcomes of early PC or mental health referrals, as well as their effect 
on patient satisfaction.  In the next cycle, a pre and post patient satisfaction survey is 
recommended.  Additionally, following the patients longitudinally over a 12- to 24-
month period would allow for a clearer understanding of the impact on decreasing ED 
visits and unintentional hospitalizations.  
Cost Analysis 
 The average cost of an oncologic ED visit in the United States is approximately 
$1,127 (Rivera et al., 2017). During the 3-month data collection period, three out of five 
consulted patients presented to the ED.  Two patients presented once and one patient 
presented twice.  The estimated cost for all four ED visits was $4,508.   
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Out of the nine patients not consulted, two presented to the ED.  One patient 
presented twice and one patient presented four times. The cost for all 6 ED visits equates 
to $6,762.   
It is the goal to apply iterations to this project, via the PDCA cycle, to achieve the 
intention of identifying high-risk patients early on in treatment and providing 
preventative interventions to reduce ED visits and hospital admissions.  Had this been 
accomplished, the potential savings would have been $11,270 in health care costs.  
Dissemination 
At the conclusion of this 3-month pilot, a stakeholder presentation exhibiting data 
and outcomes was presented to at the Hematology/Oncology Division rounds on April 5, 
2019.  On April 13, 2019, a poster presentation of the project was presented at the 52nd 
annual Western Institute of Nursing (WIN) Conference held at the Town and Country 
Convention Center in San Diego, CA (Appendix F-G). 
Sustainability 
 The institution in which this EPB project was conducted has an Internal Medicine 
Residency Program and various fellowship programs.  To extend and improve this 
project, the current plan is for a resident, fellow, or DNP student to continue with the 
initiative, implementing the discussed iterations. Projects such as this one can improve 
the quality of care for oncology and/or PC patients. 
Conclusion 
This project implemented an algorithmic approach to assess pain, functionality, 
and psychosocial states in newly diagnosed cancer patients. This was accomplished by 
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utilizing a validated pain assessment tool for the purpose of identifying high-risk patients 
for ED admission or UHA within a second-year fellow Hematology/Oncology clinic.  
Eighty-six percent of patients were correctly identified as being high-risk for ED 
or hospital admission.  The average time to perform the comprehensive pain assessment 
was approximately 23 minutes.  Four out of the five consulted patients were not familiar 
with the term or functions of palliative care.  
Future iterations include (a) implementing this project within a solid tumor clinic, 
with particular consideration to breast and gynecological malignancies; (b) providing 
more information on eligibility criteria for providers determining a designated space for 
consultation; (c) performing the consult within one to three visits of diagnosis; (d) 
administering a pre and post implementation survey for patients and providers; and, (e) 
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